Bender et al. [26] used a multiplex immunoassay platform and demonstrated a two-fold increase in IFNγ level in GBM patients compared to healthy controls, whereas other cytokines, i.e., IL-6, IL-8, and TNFα, showed no differences between groups [26]. This evidence concerns the gene IL6 and glioblastoma.